BioVentures Investors

General contacts

Investor type

PE / VC

Founded

1998

AUM

$200 M

Location

Westborough, Massachusetts, United States

Investment Ticket

$10-50 m

Investment Stage

Seed Series A Series B Late Stage (Series C+)

Region of investment

North America Europe

Investor profile last updated: 16 August, 2026

Profile

BioVentures Investors is a venture capital firm specializing in MedTech investments, headquartered in Westborough, Massachusetts. The firm was founded to focus solely on the MedTech sector, providing both financial and strategic support. The team comprises experienced professionals with expertise in regulatory affairs, clinical application, and financial management, dedicated to transforming healthcare through technology. Their collaborative approach with portfolio companies distinguishes them in the industry.

The firm invests in emerging and growth-stage MedTech companies, with a preference for next-generation implantable and disposable devices, tools, diagnostics, imaging, and healthcare IT. They typically engage in late-stage growth capital deals or early-stage investments, adapting their strategy to meet company needs. BioVentures manages significant funds, including the BioVentures MedTech Growth Capital Fund and the BioVentures MedTech Innovation Fund, although the total assets under management are not disclosed.

Notable investments by BioVentures include a range of companies focused on improving medical technology and healthcare solutions. Their portfolio includes leading firms in the MedTech sector that address high-quality and efficient healthcare delivery—though specific company names are not provided on their site.

Industry

HealthTech Life Sciences MedTech Software Medical Devices Healthcare Services Biotechnology Digital

BioVentures Investors Funds

Name	Type	Industry	Stage	Region	Size	AUM	Launch date
BioVentures Investors IV, LP	Venture Capital (VC)	Biotechnology Digital Healthcare Services Medical Devices HealthTech	Pre-seed Seed	North America	$5-10 m	$87 M	October 2016

Contacts

Name

Title

Social Networks

Marc Goldberg Managing Partner

Managing Partner

m•••@•••

Peter Feinstein Venture Partner

Venture Partner

p•••@•••

Upgrade to see contacts

YUMrBGvtCVh1czx3 YUMrBGvtCVh1czx3

YUMrBGvtCVh1czx3

[email protected]

YUMrBGvtCVh1czx3 YUMrBGvtCVh1czx3

YUMrBGvtCVh1czx3

[email protected]

YUMrBGvtCVh1czx3 YUMrBGvtCVh1czx3

YUMrBGvtCVh1czx3

[email protected]

Investment-team contacts for BioVentures Investors — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.

Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about BioVentures Investors

Is BioVentures Investors a venture capital or private equity firm?

BioVentures Investors is a venture capital and private equity firm. It backs companies at Seed, Series A, Series B and Late Stage (Series C+), writing tickets of $10-50 m.

Where is BioVentures Investors located?

BioVentures Investors is located in Westborough, Massachusetts, United States.

When was BioVentures Investors founded?

BioVentures Investors was founded in 1998.

What sectors and industries does BioVentures Investors invest in?

BioVentures Investors invests in companies and startups in HealthTech, Life Sciences, MedTech, Software, Medical Devices, Healthcare Services, Biotechnology, Digital.

What is BioVentures Investors geographical focus of investments?

BioVentures Investors invests in companies and startups in North America, Europe.

At what stages of companies and startups does BioVentures Investors typically invest in?

BioVentures Investors invests in companies and startups at Seed, Series A, Series B, Late Stage (Series C+).

What is the usual amount of BioVentures Investors investment?

BioVentures Investors usually invests $10-50 m on average.

What is the amount of assets of under management (AUM) for BioVentures Investors?

BioVentures Investors has around $200m assets under management.

When was BioVentures Investors last fund created?

BioVentures Investors last fund was created/launched in 2016-10-07

What are the contacts of BioVentures Investors?

BioVentures Investors can be reached through its website bioventuresinvestors.com and its LinkedIn page. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for BioVentures Investors — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

Can I access BioVentures Investors data via API or MCP?

Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query BioVentures Investors directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.

When was the BioVentures Investors profile last updated?

Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 16 August, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.